AwardedCzechiaGoodsCZK 123,636,050
Lutecium-177 vipivotid tetraxetan [2025]
- Published
- Published 23 September 2025
Overview
Předmětem veřejné zakázky jsou dodávky léčivého přípravku s léčivou látkou LUTECIUM-(177LU) VIPIVOTID TETRAXETAN (ATC skupina V10XX05) dle specifikace a za podmínek uvedených v příloze č. 2 výzvy.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 123,636,050
- Procedure
- Direct
- Published
- 23 September 2025
Pharmaceutical products
Award outcome
- Awarded value
- CZK 123,636,050
- Award date
- 10 September 2025
- Contract period
- — → 9 September 2028
- Novartis s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
23 September 2025
Contracting authority
Masarykův onkologický ústav
Procuring entityBrno, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.